Metraipolis › archive › dc_fc4290bc8521
Validation of the robustness of blood-based biomarkers for predicting amyloid-β positivity in Chinese populations — Europe PMC PMID:41415888
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41415888
- DOI
- 10.3389/fnagi.2025.1660755
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T23:00:31.086Z
- SHA-256 of the archived text
77f6e4f18c0467d0f881998f4a0ee9142e09c1d73ca7ffd54fbf7b1c210f22d1- Stable URL of this page
https://metraipolis.com/documento/dc_fc4290bc8521
How to cite
Validation of the robustness of blood-based biomarkers for predicting amyloid-β positivity in Chinese populations — Europe PMC PMID:41415888 — Europe PMC (en), https://europepmc.org/article/MED/41415888 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc4290bc8521 (Metraipolis archive dc_fc4290bc8521, sha256 77f6e4f18c0467d0f881998f4a0ee9142e09c1d73ca7ffd54fbf7b1c210f22d1)
BibTeX
@misc{dcfc4290bc8521,
title = {Validation of the robustness of blood-based biomarkers for predicting amyloid-β positivity in Chinese populations — Europe PMC PMID:41415888},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41415888},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc4290bc8521; sha256 77f6e4f18c0467d0f881998f4a0ee9142e09c1d73ca7ffd54fbf7b1c210f22d1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41415888. Agents can read the archived copy with the MCP tool read_document.